Abstract
To evaluate the impact of a clinical pharmacy program on health outcomes in patients with type 2 diabetes undergoing insulin therapy at a teaching hospital in Brazil. A randomized controlled trial with a 6-month follow-up period was performed in 70 adults, aged 45 years or older, with type 2 diabetes who were taking insulin and who had an HbA1c level ≥8%. Patients in the control group (CG) (n = 36) received standard care, patients in the intervention group (IG) (n = 34) received an individualized pharmacotherapeutic care plan and diabetes education. The primary outcome measure was change in HbA1c. Secondary outcomes included diabetes and medication knowledge, adherence to medication, insulin injection and home blood glucose monitoring techniques and diabetes-related quality of life. Outcomes were evaluated at baseline and 6 months using questionnaires. Diabetes knowledge, medication knowledge, adherence to medication and correct insulin injection and home blood glucose monitoring techniques significantly improved in the intervention group but remained unchanged in the control group. At the end of the study, mean HbA1c values in the control group remained unchanged but were significantly reduced in the intervention group. Diabet...Continue Reading
Citations
Sep 14, 2016·BMC Gastroenterology·Kelly L HaywardElizabeth E Powell
Feb 20, 2016·PloS One·Xuemei LiWeijun Zhang
Mar 11, 2016·PloS One·Patricia Melo AguiarSílvia Storpirtis
Apr 28, 2017·Journal of Clinical Pharmacy and Therapeutics·M Y L SiawJ Y-C Lee
Apr 7, 2018·Australian Journal of Primary Health·Marzieh NiknamiHassan Hosseinzadeh
Jun 23, 2016·Clinical Medicine Insights. Endocrinology and Diabetes·Wafaa AlSaggafJaakko Tuomilehto
Jan 10, 2018·Frontiers in Pharmacology·Linda van EikenhorstHan de Gier
Sep 5, 2018·The Cochrane Database of Systematic Reviews·Mícheál de BarraMargaret C Watson
Oct 29, 2018·International Journal of Clinical Practice·Melanie Yee Lee Siaw, Joyce Yu-Chia Lee
Aug 29, 2020·Journal of Managed Care & Specialty Pharmacy·Elizabeth L EbyMaureen J Lage
Oct 18, 2019·Journal of Pharmacy & Bioallied Sciences·Muhammad Z IqbalSyed Azhar Syed Sulaiman
Feb 6, 2020·Einstein·Marcel NogueiraVanusa Barbosa Pinto
Apr 18, 2019·Journal of Advanced Nursing·Jinhan Pamala TanRosalind Chiew-Jiat Siah
Apr 26, 2018·Frontiers in Pharmacology·Allah BukhshBey-Hing Goh
Jul 20, 2017·Current Diabetes Reports·Elizabeth KaselitzMichele Heisler
May 31, 2019·International Journal of Preventive Medicine·Maryam JahanbakhshShekoufeh Afkhami
Oct 11, 2020·Current Diabetes Reports·M Larissa Avilés-SantaNangel M Lindberg
Nov 27, 2020·The Lancet Global Health·Joseph Linju MariaPanniyammakal Jeemon
Apr 23, 2019·Journal of Patient Safety·Cherlie Magny-NormilusJeffrey L Schnipper
Jan 21, 2021·Diabetic Medicine : a Journal of the British Diabetic Association·Tigestu A DesseElizabeth Manias
Mar 23, 2021·Journal of Evaluation in Clinical Practice·Martin HeineSusan Hanekom
Feb 15, 2020·Research in Social & Administrative Pharmacy : RSAP·Lauren CadelSara J T Guilcher
Jul 5, 2021·Primary Care Diabetes·Manal M OthmanSuhail A R Doi
Jul 27, 2021·International Journal of Clinical Practice·Wei LiangKa Ming Chow
Aug 18, 2021·Saudi Pharmaceutical Journal : SPJ : the Official Publication of the Saudi Pharmaceutical Society·Selvakumari SelvaduraiLina Mariana Mohd Ali
Nov 13, 2018·Value in Health Regional Issues·Zeinab Jannoo, Naushad Mamode Khan